"I'm not interested in innovation for its own sake. I'm interested in returns for shareholders."
– Rajiv Kaul, portfolio manager with Fidelity Investments, at Deloitte Recap's Allicense meeting

To foster innovation "is why we're in this game, most of us, as corporate groups."
– Jennifer Frield Goldstein, director of Pfizer Venture Investments, at Deloitte Recap's Allicense meeting

"I'm not supposed to make money for shareholders every day."
– Patrick Mahaffy, president and CEO of Clovis Oncology Inc., at Deloitte Recap's Allicense meeting